Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic and anti-inflammatory therapy for Crohn's disease
2008-001137-99Phase 2Completed
- Sponsor
- Royal Liverpool & Broadgreen University Hospitals
- Start
- Nov 2008
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ciprofloxacin, budesonide, doxycycline and hydroxychloroquine in Crohn's disease, sponsored by Royal Liverpool & Broadgreen University Hospitals. Started Nov 2008; status: completed.
02
Drugs
ciprofloxacinbudesonidedoxycyclinehydroxychloroquine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2008-001137-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001137-99.